To validate its clinical relativity, we queried the GEPIA database for ICAM1 expression in a total of 306 patients with cervical cancer and found that the level of ICAM1 mRNA was significantly upregulated in patients with cervical cancer (Fig. 1b). Here, ICAM1 is linked to cervical carcinoma.